We suggested that differences in the levels of irisin and TNF-alpha at baseline in ADHF and non-ADHF was a result of particularities in the signature of cardiac and non-cardiac comorbidities along with therapy of HF. This evidence concerns the gene TNF and hydrops fetalis.